Aytu Biopharma Inc expected to post a loss of 95 cents a share - Earnings Preview

Aytu Biopharma

25/09/2023 21:11

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a rise
in quarterly revenue when it reports  results on September 27. 
    * The Englewood Colorado-based  company is expected to
report  a
0.9% increase in revenue to $27.694 million from $27.45 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aytu Biopharma Inc
is for
a loss of 95 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $5​, above​ its last closing price of $1.55. ​​​

This summary was machine generated September 25 at 20:11 GMT. 
All figures in US dollars  unless otherwise stated